LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
企業コードLNSR
会社名LENSAR Inc
上場日Sep 21, 2020
最高経営責任者「CEO」Curtis (Nicholas T)
従業員数140
証券種類Ordinary Share
決算期末Sep 21
本社所在地2800 Discovery Drive
都市ORLANDO
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号32826
電話番号18885367271
ウェブサイトhttps://www.lensar.com/
企業コードLNSR
上場日Sep 21, 2020
最高経営責任者「CEO」Curtis (Nicholas T)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし